KENVUE INC (KVUE) Stock Price, Forecast & Analysis
USA - NYSE:KVUE - US49177J1025 - Common Stock
KVUE Key Statistics, Chart & Performance
The current stock price of KVUE is 16.15 USD. In the past month the price increased by 7.02%. In the past year, price decreased by -32.93%.
KVUE Latest News, Press Relases and Analysis
KVUE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 51.55 | 31.21B | ||
| ELF | ELF BEAUTY INC | 22.14 | 3.88B | ||
| BRBR | BELLRING BRANDS INC | 13.73 | 3.75B | ||
| COTY | COTY INC-CL A | 16.42 | 2.73B | ||
| IPAR | INTERPARFUMS INC | 15.46 | 2.60B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.7 | 790.75M | ||
| OLPX | OLAPLEX HOLDINGS INC | 12.88 | 687.09M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.87 | 469.26M | ||
| NATR | NATURES SUNSHINE PRODS INC | 20.98 | 347.86M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.53 | 341.10M | ||
| HNST | HONEST CO INC/THE | 42.17 | 281.51M | ||
| FTLF | FITLIFE BRANDS INC | 23.49 | 165.45M |
Related stock screener links
About KVUE
Company Profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Company Info
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 22000
Phone: 19088741200
KENVUE INC / KVUE FAQ
What does KVUE do?
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Can you provide the latest stock price for KENVUE INC?
The current stock price of KVUE is 16.15 USD. The price increased by 0.56% in the last trading session.
Does KVUE stock pay dividends?
KENVUE INC (KVUE) has a dividend yield of 4.95%. The yearly dividend amount is currently 0.81.
How is the ChartMill rating for KENVUE INC?
KVUE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
When is the next dividend date for KENVUE INC (KVUE)?
The next ex-dividend date for KENVUE INC (KVUE) is November 12, 2025.
What is the expected growth for KVUE stock?
The Revenue of KENVUE INC (KVUE) is expected to decline by -2.66% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for KENVUE INC?
KENVUE INC (KVUE) currently has 22000 employees.
KVUE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to KVUE. When comparing the yearly performance of all stocks, KVUE is a bad performer in the overall market: 86.99% of all stocks are doing better.
KVUE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to KVUE. There are concerns on the financial health of KVUE while its profitability can be described as average.
KVUE Financial Highlights
Over the last trailing twelve months KVUE reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS decreased by -10.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.55% | ||
| ROA | 5.26% | ||
| ROE | 13.48% | ||
| Debt/Equity | 0.77 |
KVUE Forecast & Estimates
24 analysts have analysed KVUE and the average price target is 20.75 USD. This implies a price increase of 28.47% is expected in the next year compared to the current price of 16.15.
For the next year, analysts expect an EPS growth of -7.2% and a revenue growth -2.66% for KVUE